Mantle Cell Lymphoma: the Role of Risk-Adapted Therapy and Treatment of Relapsed Disease

被引：0
|
作者：
Meri Tarockoff
Teresita Gonzalez
Stanislav Ivanov
Jose Sandoval-Sus
机构：
[1] Memorial Healthcare System,Department of Hematology and Oncology
[2] Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System Memorial Cancer Institute,undefined
来源：
Current Oncology Reports | 2022年 / 24卷
关键词：
Mantle cell lymphoma; Relapsed/refractory mantle cell lymphoma; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1313 / 1326
页数：13
相关论文
共 50 条
  • [1] Mantle Cell Lymphoma: the Role of Risk-Adapted Therapy and Treatment of Relapsed Disease
    Tarockoff, Meri
    Gonzalez, Teresita
    Ivanov, Stanislav
    Sandoval-Sus, Jose
    CURRENT ONCOLOGY REPORTS, 2022, 24 (10) : 1313 - 1326
  • [2] Mantle cell lymphoma: a model for risk-adapted treatment approach
    Kim, Seok Jin
    BLOOD RESEARCH, 2014, 49 (01) : 1 - 2
  • [3] Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy
    Craig Moskowitz
    Cancer Chemotherapy and Pharmacology, 2002, 49 : 9 - 12
  • [4] Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy
    Moskowitz, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (Suppl 1) : S9 - S12
  • [5] Treatment of Mantle Cell Lymphoma in the Frontline Setting: Are We Ready for a Risk-Adapted Approach?
    Hammons, Lindsay
    Fenske, Timothy S.
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (07):
  • [6] Risk-adapted strategies for the treatment of Hodgkin lymphoma
    Keller, Jesse
    Carson, Kenneth R.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (10) : 1519 - 1530
  • [7] Risk-adapted therapy in follicular lymphoma: Is it time to "FLEX"?
    Tobin, Joshua W. D.
    Gandhi, Maher K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (12) : 1454 - 1456
  • [8] Integrating PET and PET/CT into the risk-adapted therapy of lymphoma
    Kasamon, Yvette L.
    Jones, Richard J.
    Wahl, Richard L.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 : 19S - 27S
  • [9] Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design
    Kumar, Anita
    Casulo, Carla
    Joffe, Erel
    Moskowitz, Craig
    Gerecitano, John
    Moskowitz, Alison
    Younes, Anas
    Drullinsky, Pamela
    Drill, Esther
    Choma, Morgan
    Grieve, Clare
    Joseph, Ashlee
    Laraque, Leana
    Schick, Dylan
    Zelenetz, Andrew
    Hamlin, Paul
    LEUKEMIA & LYMPHOMA, 2022, 63 (12) : 2889 - 2896
  • [10] Risk-adapted therapy for advanced-stage Hodgkin lymphoma
    Spinner, Michael A.
    Advani, Ranjana H.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018, : 200 - 206
12345